The first MMP in sepsis

EMBO Molecular Medicine

Volumn 3, Issue 7, 2011, Pages 367-369

  Vandenbroucke, Roosmarijn E ^a,b   Dejager, Lien ^a,b   Libert, Claude ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Mechanism; MMP; Proteases; Sepsis; Target

Indexed keywords

ACTIVATED PROTEIN C; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; INTERSTITIAL COLLAGENASE INHIBITOR; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; UNCLASSIFIED DRUG;

BLEEDING; BLOOD CLOTTING; CECUM; DRUG SAFETY; DRUG TARGETING; HUMAN; LIGATION; MOLECULAR MECHANICS; NONHUMAN; NOTE; PRIORITY JOURNAL; SEPSIS;

ANIMALS; CAPILLARY PERMEABILITY; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE 1; RECEPTOR, PAR-1; SEPSIS;

EID: 79960098757     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201100146     Document Type: Note

References (6)

1. Dejager L, Pinheiro I, Dejonckheere E, Libert C (2011) Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends Microbiol 19: 198-208.
2. Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C (2010) Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 1803: 3-19.
3. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis Nat Med 9: 517-524.
4. Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS, Lopez-Otin C, Overall CM (2007) LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2: e312.
5. Tressel SL, Kaneider NC, Kasuda S, Foley C, Koukos G, Austin K, Agarwal A, Covic L, Opal SM, Kuliopulos A (2011) A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in spesis. EMBO Mol Med DOI: 10.1002/emmm.201100145.
6. Vanlaere I, Libert C (2009) Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 22: 224-239.